(WCH) Wacker Chemie - Overview
Exchange: XETRA •
Country: Germany •
Currency: EUR •
Type: Common Stock •
ISIN: DE000WCH8881
Stock: Silicones, Polymers, Biosolutions, Polysilicon
Total Rating 23
Risk 56
Buy Signal -0.87
| Risk 5d forecast | |
|---|---|
| Volatility | 55.8% |
| Relative Tail Risk | -6.55% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.00 |
| Alpha | -15.00 |
| Character TTM | |
|---|---|
| Beta | 0.903 |
| Beta Downside | 2.037 |
| Drawdowns 3y | |
|---|---|
| Max DD | 56.81% |
| CAGR/Max DD | -0.29 |
EPS (Earnings per Share)
Revenue
Risks
Fundamental:
P/E ratio: 162.6744
Description: WCH Wacker Chemie March 04, 2026
Wacker Chemie AG (WCH) is a German specialty chemicals company founded in 1914. It operates globally through four divisions: Silicones, Polymers, Biosolutions, and Polysilicon.
The Silicones division produces various silicone-based products. The Polymers division supplies binders and additives for construction, paper, paint, coating, and adhesive industries. The Biosolutions division offers biotech and catalog products, including pharmaceutical proteins and food additives. The Polysilicon division manufactures hyperpure polysilicon, a key material in the semiconductor industry and solar energy sector.
To further understand Wacker Chemie AGs market position and financial health, consider exploring its detailed analytics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: -813.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.08 > 0.02 and ΔFCF/TA -1.69 > 1.0 |
| NWC/Revenue: 43.25% < 20% (prev 44.26%; Δ -1.01% < -1%) |
| CFO/TA 0.05 > 3% & CFO 386.4m > Net Income -813.2m |
| Net Debt (1.94b) to EBITDA (205.3m): 9.44 < 3 |
| Current Ratio: 3.02 > 1.5 & < 3 |
| Outstanding Shares: last quarter (49.7m) vs 12m ago -0.57% < -2% |
| Gross Margin: 32.19% > 18% (prev 0.17%; Δ 3202 % > 0.5%) |
| Asset Turnover: 61.06% > 50% (prev 60.81%; Δ 0.26% > 0%) |
| Interest Coverage Ratio: -0.32 > 6 (EBITDA TTM 205.3m / Interest Expense TTM 119.9m) |
Altman Z'' 3.27
| A: 0.28 (Total Current Assets 3.55b - Total Current Liabilities 1.17b) / Total Assets 8.56b |
| B: 0.46 (Retained Earnings 3.90b / Total Assets 8.56b) |
| C: -0.00 (EBIT TTM -38.7m / Avg Total Assets 8.98b) |
| D: 0.0 (Book Value of Equity 0.0 / Total Liabilities 4.14b) |
| Altman-Z'' Score: 3.27 = A |
Beneish M
| DSRI: none (Receivables none/764.6m, Revenue 5.49b/5.72b) |
| GMI: 0.54 (GM 32.19% / 17.24%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 0.96 (Revenue 5.49b / 5.72b) |
| TATA: -0.14 (NI -813.2m - CFO 386.4m) / TA 8.56b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of WCH shares?
As of March 05, 2026, the stock is trading at EUR 73.80 with a total of 124,734 shares traded.
Over the past week, the price has changed by -10.05%, over one month by -4.09%, over three months by +11.14% and over the past year by +16.12%.
Over the past week, the price has changed by -10.05%, over one month by -4.09%, over three months by +11.14% and over the past year by +16.12%.
Is WCH a buy, sell or hold?
Wacker Chemie has no consensus analysts rating.
What are the forecasts/targets for the WCH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 71.6 | -3% |
| Analysts Target Price | - | - |
WCH Fundamental Data Overview March 04, 2026
Market Cap USD = 4.27b (3.62b EUR * 1.1794 EUR.USD)
P/E Trailing = 162.6744
P/E Forward = 21.9298
P/S = 0.6505
P/B = 0.883
P/EG = 2.86
Revenue TTM = 5.49b EUR
EBIT TTM = -38.7m EUR
EBITDA TTM = 205.3m EUR
Long Term Debt = 1.77b EUR (from longTermDebt, two quarters ago)
Short Term Debt = 162.6m EUR (from shortTermDebt, two quarters ago)
Debt = 1.94b EUR (from shortLongTermDebtTotal, two quarters ago)
Net Debt = 1.94b EUR (using Total Debt 1.94b, CCE unavailable)
Enterprise Value = 5.56b EUR (3.62b + Debt 1.94b - (null CCE))
Interest Coverage Ratio = -0.32 (Ebit TTM -38.7m / Interest Expense TTM 119.9m)
EV/FCF = -8.14x (Enterprise Value 5.56b / FCF TTM -682.7m)
FCF Yield = -12.28% (FCF TTM -682.7m / Enterprise Value 5.56b)
FCF Margin = -12.44% (FCF TTM -682.7m / Revenue TTM 5.49b)
Net Margin = -14.82% (Net Income TTM -813.2m / Revenue TTM 5.49b)
Gross Margin = 32.19% ((Revenue TTM 5.49b - Cost of Revenue TTM 3.72b) / Revenue TTM)
Gross Margin QoQ = none% (prev 11.50%)
Tobins Q-Ratio = 0.65 (Enterprise Value 5.56b / Total Assets 8.56b)
Interest Expense / Debt = 0.93% (Interest Expense 18.0m / Debt 1.94b)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = -29.0m (EBIT -38.7m * (1 - 25.00%)) [loss with tax shield]
Current Ratio = 3.02 (Total Current Assets 3.55b / Total Current Liabilities 1.17b)
Debt / Equity = 0.45 (Debt 1.94b / totalStockholderEquity, two quarters ago 4.27b)
Debt / EBITDA = 9.44 (Net Debt 1.94b / EBITDA 205.3m)
Debt / FCF = -2.84 (negative FCF - burning cash) (Net Debt 1.94b / FCF TTM -682.7m)
Total Stockholder Equity = 4.47b (last 4 quarters mean from totalStockholderEquity)
RoA = -9.05% (Net Income -813.2m / Total Assets 8.56b)
RoE = -18.18% (Net Income TTM -813.2m / Total Stockholder Equity 4.47b)
RoCE = -0.62% (EBIT -38.7m / Capital Employed (Equity 4.47b + L.T.Debt 1.77b))
RoIC = -0.66% (negative operating profit) (NOPAT -29.0m / Invested Capital 4.41b)
WACC = 6.26% (E(3.62b)/V(5.56b) * Re(9.24%) + D(1.94b)/V(5.56b) * Rd(0.93%) * (1-Tc(0.25)))
Discount Rate = 9.24% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF] Fair Price = unknown (Cash Flow -682.7m)
EPS Correlation: -89.24 | EPS CAGR: -61.96% | SUE: -3.65 | # QB: 0
Revenue Correlation: -76.91 | Revenue CAGR: -12.56% | SUE: -0.53 | # QB: 0
EPS next Year (2026-12-31): EPS=0.82 | Chg7d=+0.059 | Chg30d=-0.262 | Revisions Net=-2 | Growth EPS=+105.0% | Growth Revenue=+0.1%
P/E Trailing = 162.6744
P/E Forward = 21.9298
P/S = 0.6505
P/B = 0.883
P/EG = 2.86
Revenue TTM = 5.49b EUR
EBIT TTM = -38.7m EUR
EBITDA TTM = 205.3m EUR
Long Term Debt = 1.77b EUR (from longTermDebt, two quarters ago)
Short Term Debt = 162.6m EUR (from shortTermDebt, two quarters ago)
Debt = 1.94b EUR (from shortLongTermDebtTotal, two quarters ago)
Net Debt = 1.94b EUR (using Total Debt 1.94b, CCE unavailable)
Enterprise Value = 5.56b EUR (3.62b + Debt 1.94b - (null CCE))
Interest Coverage Ratio = -0.32 (Ebit TTM -38.7m / Interest Expense TTM 119.9m)
EV/FCF = -8.14x (Enterprise Value 5.56b / FCF TTM -682.7m)
FCF Yield = -12.28% (FCF TTM -682.7m / Enterprise Value 5.56b)
FCF Margin = -12.44% (FCF TTM -682.7m / Revenue TTM 5.49b)
Net Margin = -14.82% (Net Income TTM -813.2m / Revenue TTM 5.49b)
Gross Margin = 32.19% ((Revenue TTM 5.49b - Cost of Revenue TTM 3.72b) / Revenue TTM)
Gross Margin QoQ = none% (prev 11.50%)
Tobins Q-Ratio = 0.65 (Enterprise Value 5.56b / Total Assets 8.56b)
Interest Expense / Debt = 0.93% (Interest Expense 18.0m / Debt 1.94b)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = -29.0m (EBIT -38.7m * (1 - 25.00%)) [loss with tax shield]
Current Ratio = 3.02 (Total Current Assets 3.55b / Total Current Liabilities 1.17b)
Debt / Equity = 0.45 (Debt 1.94b / totalStockholderEquity, two quarters ago 4.27b)
Debt / EBITDA = 9.44 (Net Debt 1.94b / EBITDA 205.3m)
Debt / FCF = -2.84 (negative FCF - burning cash) (Net Debt 1.94b / FCF TTM -682.7m)
Total Stockholder Equity = 4.47b (last 4 quarters mean from totalStockholderEquity)
RoA = -9.05% (Net Income -813.2m / Total Assets 8.56b)
RoE = -18.18% (Net Income TTM -813.2m / Total Stockholder Equity 4.47b)
RoCE = -0.62% (EBIT -38.7m / Capital Employed (Equity 4.47b + L.T.Debt 1.77b))
RoIC = -0.66% (negative operating profit) (NOPAT -29.0m / Invested Capital 4.41b)
WACC = 6.26% (E(3.62b)/V(5.56b) * Re(9.24%) + D(1.94b)/V(5.56b) * Rd(0.93%) * (1-Tc(0.25)))
Discount Rate = 9.24% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF] Fair Price = unknown (Cash Flow -682.7m)
EPS Correlation: -89.24 | EPS CAGR: -61.96% | SUE: -3.65 | # QB: 0
Revenue Correlation: -76.91 | Revenue CAGR: -12.56% | SUE: -0.53 | # QB: 0
EPS next Year (2026-12-31): EPS=0.82 | Chg7d=+0.059 | Chg30d=-0.262 | Revisions Net=-2 | Growth EPS=+105.0% | Growth Revenue=+0.1%